Username Password
S&P 500: 2,103.84
Change: -0.09%

EXELIXIS INC. (EXEL)

Overview
Price 3.77
Price Change Today -$0.05 (-1.31%)
P&P rating Rating: 3
Open Price $3.80
Previous Close $3.82
Daily Range $3.51 - $3.80
52-Week Range $1.26 - $4.55
Volume 6
chart
Top Buy Analysis
BUY: EXEL Rating: 3
Company: EXELIXIS INC.
Points: -48.43
Start Price: $4.77
Start Date: 05/23/2013 8:49 AM
BriansLongshots
BriansLongshots
P&P Score: 87.67
Recs:
Phase 3 trials nearing completion. Great preliminary results against various cancers.

Comments: 0 | Comment

Top Sell Analysis
SELL: EXEL Rating: 3
Company: EXELIXIS INC.
Points: 125.14
Start Price: $9.35
Start Date: 06/19/2011 9:24 AM
Hqdepot
Hqdepot
P&P Score: 47.59
Recs:
I bought at 2.99 and took a 100+ gain at 6.45. Then I watched it ratchet up to 12. Makes you want to put on a blindfold and slide quarters into a slot machine. Anyway. It looks tenuous here and the news concerning side effects of their big Phase 3 drug is not promising. I see some downside to the 6.5 area here.

Comments: 0 | Comment

Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

28 Buy
1 Sell
 
Blog Posts
User User Score Date Title Comments Last Comment
zantriocom
0.00 03/10/10 Zantrio.com Free Daily Stock Picks 3-10-2010 0
zantriocom
0.00 11/09/09 Zantrio.com Free Daily Stock Picks 11-9-09 0
Zacks_Analysts
0.00 01/18/13 Pipeline Advances at Exelixis - Analyst Blog 0
Zacks_Analysts
0.00 01/18/13 Pipeline Advances at Exelixis - Analyst Blog 0
Zacks_Analysts
0.00 12/20/10 Sanofi Expands Oncology Pipeline - Analyst Blog 0
Zacks_Analysts
0.00 07/26/10 Sanofi Launches Cancer Treatment - Analyst Blog 0
Zacks_Analysts
0.00 06/30/10 Sanofi to Acquire TargaGen - Analyst Blog 0
Zacks_Analysts
0.00 06/22/10 BMY Terminates EXEL Partnership - Analyst Blog 0
Zacks_Analysts
0.00 06/18/10 FDA Approves Sanofi Drug - Analyst Blog 0
Zacks_Analysts
0.00 06/07/10 Sanofi Expands Oncology Pipeline - Analyst Blog 0
Pages: [ 1 ]  2  >>
Commentary
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $4.77
Points: -48.43
Created: 05/23/2013
Phase 3 trials nearing completion. Great preliminary results against various cancers.

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $4.77
Points: -48.68
Created: 05/23/2013
Phase 3 trials nearing completion. Great preliminary results against various cancers.

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $4.77
Points: -48.43
Created: 05/23/2013
Phase 3 trials nearing completion. Great preliminary results against various cancers.

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $4.77
Points: -48.68
Created: 05/23/2013
Phase 3 trials nearing completion. Great preliminary results against various cancers.

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $4.77
Points: -48.43
Created: 05/23/2013
Phase 3 trials nearing completion. Great preliminary results against various cancers.

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $4.77
Points: -48.68
Created: 05/23/2013
Phase 3 trials nearing completion. Great preliminary results against various cancers.

Comments: 0 | Comment

Recs:
 
SELL: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $9.35
Points: +125.14
Created: 06/19/2011
I bought at 2.99 and took a 100+ gain at 6.45. Then I watched it ratchet up to 12. Makes you want to put on a blindfold and slide quarters into a slot machine. Anyway. It looks tenuous here and the news concerning side effects of their big Phase 3 drug is not promising. I see some downside to the 6.5 area here.

Comments: 0 | Comment

Recs:
 
SELL: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $9.35
Points: +125.46
Created: 06/19/2011
I bought at 2.99 and took a 100+ gain at 6.45. Then I watched it ratchet up to 12. Makes you want to put on a blindfold and slide quarters into a slot machine. Anyway. It looks tenuous here and the news concerning side effects of their big Phase 3 drug is not promising. I see some downside to the 6.5 area here.

Comments: 0 | Comment

Recs:
 
SELL: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $9.35
Points: +125.14
Created: 06/19/2011
I bought at 2.99 and took a 100+ gain at 6.45. Then I watched it ratchet up to 12. Makes you want to put on a blindfold and slide quarters into a slot machine. Anyway. It looks tenuous here and the news concerning side effects of their big Phase 3 drug is not promising. I see some downside to the 6.5 area here.

Comments: 0 | Comment

Recs:
 
SELL: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $9.35
Points: +125.46
Created: 06/19/2011
I bought at 2.99 and took a 100+ gain at 6.45. Then I watched it ratchet up to 12. Makes you want to put on a blindfold and slide quarters into a slot machine. Anyway. It looks tenuous here and the news concerning side effects of their big Phase 3 drug is not promising. I see some downside to the 6.5 area here.

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2   3  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
BriansLongshots 87.67 BUY Three Plus Years 05/23/2013 $4.77 $3.77
(-1.31%)
-20.96% +27.47% -48.43 view
BriansLongshots 87.67 BUY Three Plus Years 05/23/2013 $4.77 $3.77
(-1.31%)
-20.96% +27.72% -48.68 view
BriansLongshots 87.67 BUY Three Plus Years 05/23/2013 $4.77 $3.77
(-1.31%)
-20.96% +27.47% -48.43 view
BriansLongshots 87.67 BUY Three Plus Years 05/23/2013 $4.77 $3.77
(-1.31%)
-20.96% +27.72% -48.68 view
BriansLongshots 87.67 BUY Three Plus Years 05/23/2013 $4.77 $3.77
(-1.31%)
-20.96% +27.47% -48.43 view
BriansLongshots 87.67 BUY Three Plus Years 05/23/2013 $4.77 $3.77
(-1.31%)
-20.96% +27.72% -48.68 view
rtezanos 99.59 BUY Week or Less 10/19/2011 $5.57 $3.77
(-1.31%)
-32.32% +73.89% -106.20 view
rtezanos 99.59 BUY Week or Less 10/19/2011 $5.57 $3.77
(-1.31%)
-32.32% +74.23% -106.54 view
rtezanos 99.59 BUY Week or Less 10/19/2011 $5.57 $3.77
(-1.31%)
-32.32% +73.89% -106.20 view
rtezanos 99.59 BUY Week or Less 10/19/2011 $5.57 $3.77
(-1.31%)
-32.32% +74.23% -106.54 view
Pages: [ 1 ]  2   3  >>
Sponsored Links